Search for: "PFIZER V TEVA PHARMA"
Results 41 - 60
of 143
Sort by Relevance
|
Sort by Date
6 Apr 2011, 12:18 am
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) –… [read post]
29 Mar 2011, 9:19 pm
(Kluwer Patent Blog) Prezista (Darunavir) – US: Tibotec files patent infringement complaint against Teva in response to Para IV certification (Patent Docs) Provigil (Modafinil) – US: Apotex’s generic Provigil found not to infringe Cephalon patent (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: CAFC reversed summary judgment of nonobviousness in Duramed v Watson (Patent Docs) (IPBiz) Simcor (Niacin/Simvastatin) – US: Abbott files… [read post]
2 Feb 2011, 3:52 am
Meda Pharma GmbH & Co. [read post]
25 Jan 2011, 10:58 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
19 Jan 2011, 2:00 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
29 Dec 2010, 2:57 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Dec 2010, 3:01 am
Pfizer Health AB & Anor v Schwarz Pharma AG & Ors (PatLit) US: Briefing updates – AMP v. [read post]
10 Nov 2010, 1:11 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Nov 2010, 5:10 am
Yet the statement in Geneva took on a life of its own, as in Pfizer, Inc. v. [read post]
3 Nov 2010, 1:21 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
7 Sep 2010, 6:10 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
31 Aug 2010, 10:01 pm
– state of research and development of new drugs in Indian pharma industry (Spicy IP) US: The Financial Times’ take on gene patenting (Patent Docs) US: Seattle Biotech companies fight over allegedly similar names: Mirina Corp. v. [read post]
18 Aug 2010, 12:19 am
(Patent Docs) Asacol (Mesalamine) – US: Patent infringement complaint filed following a Paragraph IV certification: Medeva Pharma Suisse A.G. et al. v. [read post]
10 Aug 2010, 8:44 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc.; Abbott Laboratories et al. v. [read post]
7 Jul 2010, 5:14 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Jul 2010, 6:03 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
23 Jun 2010, 10:28 pm
Teva Pharmaceuticals USA, Inc. et al. [read post]
10 Jun 2010, 3:58 am
Teva et al.; Teva et al. v. [read post]
